Press Clarevia Ventures Welcomes Cheryl R. Blanchard, Ph.D., as Executive in Residence Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) HistoSonics Announces Financing with Participation from Yosemite Among Other Strategic Investors HistoSonics Receives Landmark TFDA Approval in Taiwan, Accelerating Global Expansion Andera Partners Leads $20 Million Series D Financing in Rivermark Medical. HistoSonics Moves to Advance Additional Histotripsy Applications Announcing FDA Submission for Kidney Tumors Clarevia Ventures Welcomes Margaret Kaczor Andrew as Venture Partner After 40 Years, Venture Investors Rebrands as Clarevia Ventures, Marking a Clearer Identity for Its Next Chapter in Healthcare Investing Ann Arbor VC firm rebrands after its 40-year anniversary Iterion Therapeutics Expands Clinical Development of Tegavivint HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH) The 10 Most Influential Health and Life Science Companies of 2026 TIME100 Health 2026: Zhen Xu of HistoSonics Iterion Therapeutics Announces First Patient Dosed in Clinical Study of Tegavivint Otsuka Announces FDA Acceptance and Priority Review of New Drug Application for Centanafadine First Cancer Patient Screened Using Elphas Live Platform at inDNA Life Sciences in India Michigan Venture Capital Association Showcases Record-Breaking Achievements at 2025 Awards HistoSonics Raises $250M Led by New Owners Elephas Biosciences Raises $40m to Accelerate Commercialization of its Live Tumor Profiling Platform ViaLase Announces First Patient Treated in IDE Clinical Trial Evaluating Its Femtosecond Laser Trabeculotomy for Open-Angle Glaucoma He came to Michigan for the auto industry. Now he builds billion-dollar companies. Trinity Capital Inc. Provides $30 Million in Growth Capital to Elucent Medical Invenra and Orion Announce Discovery Service and Commercial License… Blue Cross Blue Shield of Massachusetts Adds New Virtual Care… NVCA Announces HistoSonics as 2025 Startup Innovator This Company Treats Liver Tumors By Liquefying Them With Ultrasound Waves Why These 10 Medical Device Makers Are The Most Innovative… 2025 Best Tech Startups In Wisconsin Rivermark Medical Announces First Patient Enrolled In Rapid III Clinical… HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control… HistoSonics Secures First Insurance Coverage For Histotripsy System Invenra Launches T-Body™ Trispecific Platform To Advance Next-Generation… Elucent Medical Receives FDA Breakthrough Device Designation… 9 Federally Funded Scientific Breakthroughs That Changed Everything FDA Grants Breakthrough Device Status For Elucent’s EnVisio X1 System HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors Liver Tumor Therapy Company HistoSonics Valued at $2.25 Billion in Sale Bezos-backed group acquires UM spinout company in $2.25B private deal Vanguards of Health Care: HistoSonics Fights Cancer with Ultrasound Exclusive: Clarevia raises $80M Ann Arbor VC firm launches $80M fund focusing on university spinouts Visana Health Raises $24M Series A to Scale Virtual-First Women’s Health Clinic Clarevia talks latest investments
